| Frederick T Warner, MD | |
|
13677 W Mcdowell Rd, Goodyear, AZ 85395-2635 | |
| (623) 882-1500 | |
| Not Available |
| Full Name | Frederick T Warner |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 24 Years |
| Location | 13677 W Mcdowell Rd, Goodyear, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164462420 | NPI | - | NPPES |
| 236934 | Medicaid | SC |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Emergency Hospital | San antonio, TX | Hospital |
| Banner Ironwood Medical Center | Queen creek, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sierra Estrellas Emergency Physicians Llc | 5193002954 | 30 |
| Emergency Professional Services Pc | 6901707272 | 70 |
News Archive
Meda has in-licensed exclusive rights to Ceplene (histamine dihydrochloride) from EpiCept Corporation, a US-based biopharmaceutical company.
Physicians have long been puzzled by a condition called intracranial arterial dolichoectasia, in which the larger arteries of the brain become elongated and misshapen.
Bionic Vision Technologies Pty Ltd today announced medical researchers had successfully restored a sense of vision in four blind people with its bionic eye as part of a clinical trial in Melbourne.
A drug shown to be effective in the treatment of babies with the rare muscle-wasting disease spinal muscular atrophy may be effective for muscle control even when treatment is started in children seven months and older, according to a study published in the August 29, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology. Previous studies focused on children younger than seven months old.
› Verified 7 days ago
| Entity Name | Emergency Professional Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518984210 PECOS PAC ID: 6901707272 Enrollment ID: O20040119000693 |
News Archive
Meda has in-licensed exclusive rights to Ceplene (histamine dihydrochloride) from EpiCept Corporation, a US-based biopharmaceutical company.
Physicians have long been puzzled by a condition called intracranial arterial dolichoectasia, in which the larger arteries of the brain become elongated and misshapen.
Bionic Vision Technologies Pty Ltd today announced medical researchers had successfully restored a sense of vision in four blind people with its bionic eye as part of a clinical trial in Melbourne.
A drug shown to be effective in the treatment of babies with the rare muscle-wasting disease spinal muscular atrophy may be effective for muscle control even when treatment is started in children seven months and older, according to a study published in the August 29, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology. Previous studies focused on children younger than seven months old.
› Verified 7 days ago
| Entity Name | Tempe Emergency Physicians Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376934315 PECOS PAC ID: 2365337300 Enrollment ID: O20040218000500 |
News Archive
Meda has in-licensed exclusive rights to Ceplene (histamine dihydrochloride) from EpiCept Corporation, a US-based biopharmaceutical company.
Physicians have long been puzzled by a condition called intracranial arterial dolichoectasia, in which the larger arteries of the brain become elongated and misshapen.
Bionic Vision Technologies Pty Ltd today announced medical researchers had successfully restored a sense of vision in four blind people with its bionic eye as part of a clinical trial in Melbourne.
A drug shown to be effective in the treatment of babies with the rare muscle-wasting disease spinal muscular atrophy may be effective for muscle control even when treatment is started in children seven months and older, according to a study published in the August 29, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology. Previous studies focused on children younger than seven months old.
› Verified 7 days ago
| Entity Name | Emergency Physicians Southwest Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912053752 PECOS PAC ID: 2264538529 Enrollment ID: O20070502000382 |
News Archive
Meda has in-licensed exclusive rights to Ceplene (histamine dihydrochloride) from EpiCept Corporation, a US-based biopharmaceutical company.
Physicians have long been puzzled by a condition called intracranial arterial dolichoectasia, in which the larger arteries of the brain become elongated and misshapen.
Bionic Vision Technologies Pty Ltd today announced medical researchers had successfully restored a sense of vision in four blind people with its bionic eye as part of a clinical trial in Melbourne.
A drug shown to be effective in the treatment of babies with the rare muscle-wasting disease spinal muscular atrophy may be effective for muscle control even when treatment is started in children seven months and older, according to a study published in the August 29, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology. Previous studies focused on children younger than seven months old.
› Verified 7 days ago
| Entity Name | Arizona Emergency Medicine Specialists Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134439706 PECOS PAC ID: 8921295684 Enrollment ID: O20110208000837 |
News Archive
Meda has in-licensed exclusive rights to Ceplene (histamine dihydrochloride) from EpiCept Corporation, a US-based biopharmaceutical company.
Physicians have long been puzzled by a condition called intracranial arterial dolichoectasia, in which the larger arteries of the brain become elongated and misshapen.
Bionic Vision Technologies Pty Ltd today announced medical researchers had successfully restored a sense of vision in four blind people with its bionic eye as part of a clinical trial in Melbourne.
A drug shown to be effective in the treatment of babies with the rare muscle-wasting disease spinal muscular atrophy may be effective for muscle control even when treatment is started in children seven months and older, according to a study published in the August 29, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology. Previous studies focused on children younger than seven months old.
› Verified 7 days ago
| Entity Name | Emergency Group Of Arizona Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215275433 PECOS PAC ID: 1355596644 Enrollment ID: O20130313000442 |
News Archive
Meda has in-licensed exclusive rights to Ceplene (histamine dihydrochloride) from EpiCept Corporation, a US-based biopharmaceutical company.
Physicians have long been puzzled by a condition called intracranial arterial dolichoectasia, in which the larger arteries of the brain become elongated and misshapen.
Bionic Vision Technologies Pty Ltd today announced medical researchers had successfully restored a sense of vision in four blind people with its bionic eye as part of a clinical trial in Melbourne.
A drug shown to be effective in the treatment of babies with the rare muscle-wasting disease spinal muscular atrophy may be effective for muscle control even when treatment is started in children seven months and older, according to a study published in the August 29, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology. Previous studies focused on children younger than seven months old.
› Verified 7 days ago
| Entity Name | Innova Emergency Medical Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295178978 PECOS PAC ID: 2860633435 Enrollment ID: O20160525000770 |
News Archive
Meda has in-licensed exclusive rights to Ceplene (histamine dihydrochloride) from EpiCept Corporation, a US-based biopharmaceutical company.
Physicians have long been puzzled by a condition called intracranial arterial dolichoectasia, in which the larger arteries of the brain become elongated and misshapen.
Bionic Vision Technologies Pty Ltd today announced medical researchers had successfully restored a sense of vision in four blind people with its bionic eye as part of a clinical trial in Melbourne.
A drug shown to be effective in the treatment of babies with the rare muscle-wasting disease spinal muscular atrophy may be effective for muscle control even when treatment is started in children seven months and older, according to a study published in the August 29, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology. Previous studies focused on children younger than seven months old.
› Verified 7 days ago
| Entity Name | Sound Physicians Emergency Medicine Of Arizona Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700328663 PECOS PAC ID: 5799066650 Enrollment ID: O20170109000725 |
News Archive
Meda has in-licensed exclusive rights to Ceplene (histamine dihydrochloride) from EpiCept Corporation, a US-based biopharmaceutical company.
Physicians have long been puzzled by a condition called intracranial arterial dolichoectasia, in which the larger arteries of the brain become elongated and misshapen.
Bionic Vision Technologies Pty Ltd today announced medical researchers had successfully restored a sense of vision in four blind people with its bionic eye as part of a clinical trial in Melbourne.
A drug shown to be effective in the treatment of babies with the rare muscle-wasting disease spinal muscular atrophy may be effective for muscle control even when treatment is started in children seven months and older, according to a study published in the August 29, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology. Previous studies focused on children younger than seven months old.
› Verified 7 days ago
| Entity Name | Sierra Estrellas Emergency Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578001319 PECOS PAC ID: 5193002954 Enrollment ID: O20170503001852 |
News Archive
Meda has in-licensed exclusive rights to Ceplene (histamine dihydrochloride) from EpiCept Corporation, a US-based biopharmaceutical company.
Physicians have long been puzzled by a condition called intracranial arterial dolichoectasia, in which the larger arteries of the brain become elongated and misshapen.
Bionic Vision Technologies Pty Ltd today announced medical researchers had successfully restored a sense of vision in four blind people with its bionic eye as part of a clinical trial in Melbourne.
A drug shown to be effective in the treatment of babies with the rare muscle-wasting disease spinal muscular atrophy may be effective for muscle control even when treatment is started in children seven months and older, according to a study published in the August 29, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology. Previous studies focused on children younger than seven months old.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Frederick T Warner, MD Po Box 10760, Westminster, CA 92685-0760 Ph: (800) 396-3437 | Frederick T Warner, MD 13677 W Mcdowell Rd, Goodyear, AZ 85395-2635 Ph: (623) 882-1500 |
News Archive
Meda has in-licensed exclusive rights to Ceplene (histamine dihydrochloride) from EpiCept Corporation, a US-based biopharmaceutical company.
Physicians have long been puzzled by a condition called intracranial arterial dolichoectasia, in which the larger arteries of the brain become elongated and misshapen.
Bionic Vision Technologies Pty Ltd today announced medical researchers had successfully restored a sense of vision in four blind people with its bionic eye as part of a clinical trial in Melbourne.
A drug shown to be effective in the treatment of babies with the rare muscle-wasting disease spinal muscular atrophy may be effective for muscle control even when treatment is started in children seven months and older, according to a study published in the August 29, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology. Previous studies focused on children younger than seven months old.
› Verified 7 days ago
Brendan Davis, PA-C Emergency Medicine Medicare: Medicare Enrolled Practice Location: 13677 W Mcdowell Rd, Goodyear, AZ 85395 Phone: 623-882-1500 | |
Dr. George Shepard Iii, MD MBA Emergency Medicine Medicare: Medicare Enrolled Practice Location: 13677 W Mcdowell Rd, Goodyear, AZ 85338 Phone: 623-882-1500 | |
Dr. Timothy Owen Pfeiffer, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 13677 W Mcdowell Rd, Goodyear, AZ 85338 Phone: 623-882-1500 | |
Mr. David R Murray, PA Emergency Medicine Medicare: Medicare Enrolled Practice Location: 13677 W Mcdowell Rd, Goodyear, AZ 85338 Phone: 623-882-1500 | |
Michel Dagher, D.O. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 13677 W Mcdowell Rd, Goodyear, AZ 85395 Phone: 623-882-1522 | |
Ms. Julia Annette Gresham, PA Emergency Medicine Medicare: Medicare Enrolled Practice Location: 13677 W Mcdowell Rd, Goodyear, AZ 85338 Phone: 623-882-1500 |